Alexandre Lautrette
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexandre Lautrette has a total of 364 co-authors. Here are the top co-authors by number of shared publications:
- Bertrand Souweine
Medical Intensive Care Unit, Gabriel-Montpied Hospital, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France
8 shared publications - Michael Darmon
Université Paris-Saclay, CEA, List, F-91120 Palaiseau, France
8 shared publications Bertrand Souweine
Medical Intensive Care Unit, Intensive Care Medicine, Montpied Teaching Hospital, Clermont-Ferrand, Cedex 1, France
6 shared publicationsCarole Schwebel
Medical Intensive Care Unit, Albert Michallon Teaching Hospital , Grenoble, France
5 shared publications- Alexandre Boyer
Medical Intensive Care Unit, CHU Bordeaux, France
4 shared publications - Ali Ait Hssain
Medical Intensive Care Unit, Hamad General Hospital, Doha, Qatar; Department of Medicine, Weill Cornell Medical College, Doha, Qatar; College of Health and Life Science, Hamad Bin Khalifa University, Doha, Qatar
4 shared publications
Latest Publications
- 4 February 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (5) , 1081-1082
Reply to Shi et al.: ICU visitation policies: no harm found, or harm missed?
- 4 February 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (5) , 1081-1082
Reply to Shi et al.: ICU visitation policies: no harm found, or harm missed?
- 4 November 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (1) , 188-190
Environmental sustainability in ICU: what motivates healthcare workers?
- 4 November 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (1) , 188-190
Environmental sustainability in ICU: what motivates healthcare workers?
- Open Access
- 23 July 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (2) , 303-314
Impact of Visitation Restrictions in ICU on Psychological Symptoms in Family Members: Experience of the COVID-19 Pandemic
Rationale: The coronavirus disease (COVID-19) pandemic required unprecedented measures, including visitation restrictions. Objectives: To assess their impact on psychological symptoms (anxiety–depression, post-traumatic stress disorder [PTSD]) among ICU family members. Methods: In this prospective multicenter quasiexperimental study, family members of patients with invasive mechanical ventilation with or without COVID-19 were enrolled during one of three periods (March 15 to June 5), subject to visitation restriction policies mandated by French health authorities: forbidden (2020, n = 304), restricted (2021, n = 294), and unrestricted (2022, n = 213). Primary outcome was prevalence of anxiety–depression symptoms in family members 90 days after ICU discharge. Measurements and Main Results: Among 811 members, prevalence of anxiety–depression symptoms did not significantly differ across the three periods (57.2%, 56.8% and 61.5% [P = 0.52]; unrestricted vs. restricted visitations: relative risk [RR], 1.08 [95% confidence interval (CI), 0.94–1.25; P = 0.28]; unrestricted vs. forbidden visitations: RR, 1.08 [95% CI, 0.93–1.24; P = 0.33]). Similar findings were observed for PTSD risk (36.5%, 40.8%, and 34.3%; P = 0.29). Anxiety–depression symptoms were associated with female relatives of patients (adjusted RR [aRR], 1.78 [95% CI, 1.28–2.46]; P = 0.001), dissatisfaction with the ICU team’s communication (aRR, 1.83 [95% CI, 1.22–2.74]; P = 0.004), and spouses of patients (aRR, 2.15 [95% CI, 1.42–3.26]; P < 0.001). For PTSD, these risk factors were also significant, in addition to COVID-19 (aRR, 1.52 [95% CI, 1.10–2.10]; P = 0.01) and patient death in the ICU (aRR, 2.59 [95% CI, 1.91–3.51]; P < 0.001). Conclusions: This study does not support the hypothesis that visitation restriction policies during the COVID-19 pandemic exacerbated the high prevalence of long-term psychological symptoms among ICU family members.Clinical trial registered with www.clinicaltrials.gov (NCT 04430049).
- 23 July 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (2) , 303-314
Open AccessImpact of Visitation Restrictions in ICU on Psychological Symptoms in Family Members: Experience of the COVID-19 Pandemic
Rationale: The coronavirus disease (COVID-19) pandemic required unprecedented measures, including visitation restrictions. Objectives: To assess their impact on psychological symptoms (anxiety–depression, post-traumatic stress disorder [PTSD]) among ICU family members. Methods: In this prospective multicenter quasiexperimental study, family members of patients with invasive mechanical ventilation with or without COVID-19 were enrolled during one of three periods (March 15 to June 5), subject to visitation restriction policies mandated by French health authorities: forbidden (2020, n = 304), restricted (2021, n = 294), and unrestricted (2022, n = 213). Primary outcome was prevalence of anxiety–depression symptoms in family members 90 days after ICU discharge. Measurements and Main Results: Among 811 members, prevalence of anxiety–depression symptoms did not significantly differ across the three periods (57.2%, 56.8% and 61.5% [P = 0.52]; unrestricted vs. restricted visitations: relative risk [RR], 1.08 [95% confidence interval (CI), 0.94–1.25; P = 0.28]; unrestricted vs. forbidden visitations: RR, 1.08 [95% CI, 0.93–1.24; P = 0.33]). Similar findings were observed for PTSD risk (36.5%, 40.8%, and 34.3%; P = 0.29). Anxiety–depression symptoms were associated with female relatives of patients (adjusted RR [aRR], 1.78 [95% CI, 1.28–2.46]; P = 0.001), dissatisfaction with the ICU team’s communication (aRR, 1.83 [95% CI, 1.22–2.74]; P = 0.004), and spouses of patients (aRR, 2.15 [95% CI, 1.42–3.26]; P < 0.001). For PTSD, these risk factors were also significant, in addition to COVID-19 (aRR, 1.52 [95% CI, 1.10–2.10]; P = 0.01) and patient death in the ICU (aRR, 2.59 [95% CI, 1.91–3.51]; P < 0.001). Conclusions: This study does not support the hypothesis that visitation restriction policies during the COVID-19 pandemic exacerbated the high prevalence of long-term psychological symptoms among ICU family members.Clinical trial registered with www.clinicaltrials.gov (NCT 04430049).
- Open Access
- 13 March 2024
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 25 (9) , 1529-1537
Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study
Background: Better cost-awareness is a prerogative in achieving the best benefit/risk/cost ratio in the care. We aimed to assess the cost-awareness of intensivists in their daily clinical practice and to identify factors associated with accurate estimate of cost (50–150% of the real cost). Methods: We performed a prospective observational study in seven French ICUs. We compared the estimate of intensivists of the daily costs of caring with the real costs on a given day. The estimates covered five categories (drugs, laboratory tests, imaging modalities, medical devices, and waste) whose sum represented the overall cost. Results: Of the 234 estimates made by 65 intensivists, 70 (29.9%) were accurate. The median overall cost estimate (€330 [170; 620]) was significantly higher than the real cost (€178 [124; 239], p < 0.001). This overestimation was found in four categories, in particular for waste (€40 [15; 100] vs. €1.1 [0.6; 2.3], p < 0.001). Only the laboratory tests were underestimated (€65 [30; 120] vs. €106 [79; 138], p < 0.001). Being aware of the financial impact of prescriptions was factor associated with accurate estimate (OR: 5.05, 95%CI:1.47–17.4, p = 0.01). However, feeling able to accurately perform estimation was factor negatively associated with accurate estimate (OR: 0.11, 95%CI: 0.02–0.71, p = 0.02). Conclusion: French intensivists have a poor awareness of costs in their daily clinical practice. Raising awareness of the financial impact of prescriptions, and of the cost of laboratory tests and waste are the main areas for improvement that could help achieve the objective of the best care at the best cost.
- 13 March 2024
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 25 (9) , 1529-1537
Open AccessCost awareness among intensivists in their daily clinical practice: a prospective multicentre study
Background: Better cost-awareness is a prerogative in achieving the best benefit/risk/cost ratio in the care. We aimed to assess the cost-awareness of intensivists in their daily clinical practice and to identify factors associated with accurate estimate of cost (50–150% of the real cost). Methods: We performed a prospective observational study in seven French ICUs. We compared the estimate of intensivists of the daily costs of caring with the real costs on a given day. The estimates covered five categories (drugs, laboratory tests, imaging modalities, medical devices, and waste) whose sum represented the overall cost. Results: Of the 234 estimates made by 65 intensivists, 70 (29.9%) were accurate. The median overall cost estimate (€330 [170; 620]) was significantly higher than the real cost (€178 [124; 239], p < 0.001). This overestimation was found in four categories, in particular for waste (€40 [15; 100] vs. €1.1 [0.6; 2.3], p < 0.001). Only the laboratory tests were underestimated (€65 [30; 120] vs. €106 [79; 138], p < 0.001). Being aware of the financial impact of prescriptions was factor associated with accurate estimate (OR: 5.05, 95%CI:1.47–17.4, p = 0.01). However, feeling able to accurately perform estimation was factor negatively associated with accurate estimate (OR: 0.11, 95%CI: 0.02–0.71, p = 0.02). Conclusion: French intensivists have a poor awareness of costs in their daily clinical practice. Raising awareness of the financial impact of prescriptions, and of the cost of laboratory tests and waste are the main areas for improvement that could help achieve the objective of the best care at the best cost.
- Open Access
- 29 November 2022
- Published by Springer Nature in Critical Care
- Vol. 26 (1) , 1-10
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial
Background: Acute kidney injury (AKI) requiring renal replacement therapy (RRT) is a serious complication in the ICU that results in increased mortality and risk of chronic kidney disease (CKD). Some studies suggest RRT modality may have an impact on long-term renal recovery after AKI. However, other predictive factors of severe long-term CKD in ICU patients with AKI requiring RRT are unknown. Methods: We performed an ancillary study of the multicenter ELVIS trial in the population with AKI requiring RRT. Patients alive 3 months after RRT initiation were eligible. Serum creatinine levels available at 3, 6 and 12 months and 3 and 5 years were recorded. CKD stage was determined according to the glomerular filtration rate as estimated by the CKD-EPI formula. At each timepoint, two groups of patients were compared, a no/mild CKD group with normal or mildly to moderately decreased renal function (stages 1, 2 and 3 of the international classification) and a severe CKD group (stages 4 and 5). Our objective was to identify predictive factors of severe long-term CKD. Results: Of the 287 eligible patients, 183 had follow-up at 3 months, 136 (74.3%) from the no/mild CKD group and 47 (25.7%) from the severe CKD group, and 122 patients at 5 years comprising 96 (78.7%) from the no/mild CKD group and 26 (21.3%) from the severe CKD group. Multivariate analysis showed that a long RRT period was associated with severe CKD up to 12 months (ORM12 = 1.03 95% CI [1.02–1.05] per day) and that a high SOFA score at the initiation of RRT was not associated with severe CKD up to 5 years (ORM60 = 0.85 95% CI [0.77–0.93] per point). Conclusion: Severe long-term CKD was found in 21% of ICU survivors who underwent RRT for AKI. The duration of the RRT in AKI patients was identified as a new predictive factor for severe long-term CKD. This finding should be taken into consideration in future studies on the prognosis of ICU patients with AKI requiring RRT. Trial registration ELVIS trial was registered with ClinicalTrials.gov, number: NCT00875069 (June 16, 2014), and this ancillary study was registered with ClinicalTrials.gov, number: NCT03302624 (October 6, 2017).
- 29 November 2022
- Published by Springer Nature in Critical Care
- Vol. 26 (1) , 1-10
Open AccessPredictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial
Background: Acute kidney injury (AKI) requiring renal replacement therapy (RRT) is a serious complication in the ICU that results in increased mortality and risk of chronic kidney disease (CKD). Some studies suggest RRT modality may have an impact on long-term renal recovery after AKI. However, other predictive factors of severe long-term CKD in ICU patients with AKI requiring RRT are unknown. Methods: We performed an ancillary study of the multicenter ELVIS trial in the population with AKI requiring RRT. Patients alive 3 months after RRT initiation were eligible. Serum creatinine levels available at 3, 6 and 12 months and 3 and 5 years were recorded. CKD stage was determined according to the glomerular filtration rate as estimated by the CKD-EPI formula. At each timepoint, two groups of patients were compared, a no/mild CKD group with normal or mildly to moderately decreased renal function (stages 1, 2 and 3 of the international classification) and a severe CKD group (stages 4 and 5). Our objective was to identify predictive factors of severe long-term CKD. Results: Of the 287 eligible patients, 183 had follow-up at 3 months, 136 (74.3%) from the no/mild CKD group and 47 (25.7%) from the severe CKD group, and 122 patients at 5 years comprising 96 (78.7%) from the no/mild CKD group and 26 (21.3%) from the severe CKD group. Multivariate analysis showed that a long RRT period was associated with severe CKD up to 12 months (ORM12 = 1.03 95% CI [1.02–1.05] per day) and that a high SOFA score at the initiation of RRT was not associated with severe CKD up to 5 years (ORM60 = 0.85 95% CI [0.77–0.93] per point). Conclusion: Severe long-term CKD was found in 21% of ICU survivors who underwent RRT for AKI. The duration of the RRT in AKI patients was identified as a new predictive factor for severe long-term CKD. This finding should be taken into consideration in future studies on the prognosis of ICU patients with AKI requiring RRT. Trial registration ELVIS trial was registered with ClinicalTrials.gov, number: NCT00875069 (June 16, 2014), and this ancillary study was registered with ClinicalTrials.gov, number: NCT03302624 (October 6, 2017).
- Open Access
- 24 August 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (8) , e0272835
Association between proteinuria trajectories and outcomes in critically ill patients with sepsis or shock
Background: Proteinuria results from kidney damage and can be a predictor of illness severity and mortality in the intensive care unit (ICU). However, the optimal timing of proteinuria measurements and the reference values remain undetermined. Our objective was to identify the patterns of proteinuria change associated with mortality in ICU patients with sepsis or shock. Methods: This monocentric retrospective cohort study performed from April 2010 to April 2018 involved all ICU patients with sepsis or shock and at least two measurements of proteinuria from a 24h-urine collection during the first 10 days of ICU stay, the first of which was made within 48h after ICU admission. We identified proteinuria trajectories by a semi-parametric mixture model and analysed the association between the trajectories and the mortality at day 28 by Cox proportional-hazards model. Results: A total of 3,344 measurements of proteinuria from 659 patients were analysed. Four proteinuria trajectories were identified. Trajectories 1, 2, 3 and 4 comprised 127, 421, 60 and 51 patients, and were characterized by a first proteinuria of 1.14 [0.66–1.55], 0.52 [0.26–0.91], 2.92 [2.38–3.84] and 2.58 [1.75–3.32] g/24h (p2g/24h). Only, the proteinuria of trajectory 4 increased within 3 days following the first measurement and was associated with increased mortality at day 28 (hazard ratio: 2.36 95%CI [1.07–5.19], p = 0.03), regardless of acute renal failure. The factors associated with trajectory 4 were cancer (relative risk: 8.91 95%CI [2.09–38.02], p = 0.003) and use of inotropic drugs (relative risk: 0.17 95%CI [0.04–0.69], p = 0.01). Conclusion: This exploratory study of ICU patients with sepsis or shock identified four proteinuria trajectories with distinct patterns of proteinuria change over time and mortality rates. These results provide novel insights into renal pathophysiology and may be helpful to investigate subphenotypes of kidney injury among ICU patients in future studies.
- 24 August 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (8) , e0272835
Open AccessAssociation between proteinuria trajectories and outcomes in critically ill patients with sepsis or shock
Background: Proteinuria results from kidney damage and can be a predictor of illness severity and mortality in the intensive care unit (ICU). However, the optimal timing of proteinuria measurements and the reference values remain undetermined. Our objective was to identify the patterns of proteinuria change associated with mortality in ICU patients with sepsis or shock. Methods: This monocentric retrospective cohort study performed from April 2010 to April 2018 involved all ICU patients with sepsis or shock and at least two measurements of proteinuria from a 24h-urine collection during the first 10 days of ICU stay, the first of which was made within 48h after ICU admission. We identified proteinuria trajectories by a semi-parametric mixture model and analysed the association between the trajectories and the mortality at day 28 by Cox proportional-hazards model. Results: A total of 3,344 measurements of proteinuria from 659 patients were analysed. Four proteinuria trajectories were identified. Trajectories 1, 2, 3 and 4 comprised 127, 421, 60 and 51 patients, and were characterized by a first proteinuria of 1.14 [0.66–1.55], 0.52 [0.26–0.91], 2.92 [2.38–3.84] and 2.58 [1.75–3.32] g/24h (p2g/24h). Only, the proteinuria of trajectory 4 increased within 3 days following the first measurement and was associated with increased mortality at day 28 (hazard ratio: 2.36 95%CI [1.07–5.19], p = 0.03), regardless of acute renal failure. The factors associated with trajectory 4 were cancer (relative risk: 8.91 95%CI [2.09–38.02], p = 0.003) and use of inotropic drugs (relative risk: 0.17 95%CI [0.04–0.69], p = 0.01). Conclusion: This exploratory study of ICU patients with sepsis or shock identified four proteinuria trajectories with distinct patterns of proteinuria change over time and mortality rates. These results provide novel insights into renal pathophysiology and may be helpful to investigate subphenotypes of kidney injury among ICU patients in future studies.
- 23 February 2022
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 70, 103225
We need to better recognise and value the contribution of nurses to end-of-life care (Bloomer, ICCN 2022)
- 23 February 2022
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 70, 103225
We need to better recognise and value the contribution of nurses to end-of-life care (Bloomer, ICCN 2022)
- 1 February 2022
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 68, 103138
Changes in intensive care unit nurse involvement in end of life decision making between 1999 and 2016: Descriptive comparative study
- 1 February 2022
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 68, 103138
Changes in intensive care unit nurse involvement in end of life decision making between 1999 and 2016: Descriptive comparative study
- 21 January 2022
- Published by Elsevier in Journal of Critical Care
- Vol. 69, 153983
Performance of renal Doppler to predict the occurrence of acute kidney injury in patients without acute kidney injury at admission
- 21 January 2022
- Published by Elsevier in Journal of Critical Care
- Vol. 69, 153983
Performance of renal Doppler to predict the occurrence of acute kidney injury in patients without acute kidney injury at admission
- 30 November 2021
- Published by Societe de Reanimation de Langue Francaise in Médecine Intensive Réanimation
- Vol. 30 (4) , 373-378
Le sevrage de l’épuration extra rénale dans l’insuffisance rénale aiguë du patient critique
L’insuffisance rénale aiguë survient chez plus de la moitié des patients en soins critiques dont 10 % nécessitent une épuration extra-rénale (EER). Alors que la majorité des patients survivants sont sevrés de l’EER, il n’existe pas de recommandations formalisées du sevrage. Une prolongation injustifiée de l’EER ou son arrêt prématuré expose, dans les deux cas, le patient à des complications dommageables. Le sevrage de l’EER doit être réalisé, en conséquence, le plus précocement et dans les meilleures conditions possibles. Cette revue se propose d’apporter les justifications d’un sevrage précoce de l’EER, les éléments susceptibles de le guider, et ses modalités pratiques.
- 30 November 2021
- Published by Societe de Reanimation de Langue Francaise in Médecine Intensive Réanimation
- Vol. 30 (4) , 373-378
Le sevrage de l’épuration extra rénale dans l’insuffisance rénale aiguë du patient critique
L’insuffisance rénale aiguë survient chez plus de la moitié des patients en soins critiques dont 10 % nécessitent une épuration extra-rénale (EER). Alors que la majorité des patients survivants sont sevrés de l’EER, il n’existe pas de recommandations formalisées du sevrage. Une prolongation injustifiée de l’EER ou son arrêt prématuré expose, dans les deux cas, le patient à des complications dommageables. Le sevrage de l’EER doit être réalisé, en conséquence, le plus précocement et dans les meilleures conditions possibles. Cette revue se propose d’apporter les justifications d’un sevrage précoce de l’EER, les éléments susceptibles de le guider, et ses modalités pratiques.